Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation
- 1 December 2016
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 173, 147-148
- https://doi.org/10.1016/j.clim.2016.10.003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Palmoplantar Pustular Psoriasis Induced by Adalimumab: A Case Report and Literature ReviewImmunotherapy, 2015
- A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumabBritish Journal of Dermatology, 2014
- Jakpot! New small molecules in autoimmune and inflammatory diseasesExperimental Dermatology, 2013
- Increased expression of IL‐17A and limited involvement of IL‐23 in patients with palmo‐plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trialJournal of the European Academy of Dermatology and Venereology, 2013
- Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritisJoint Bone Spine, 2012
- Ustekinumab Treatment of TNF Antagonist-Induced Paradoxical Psoriasis Flare in a Patient with Psoriatic Arthritis: Case Report and ReviewDermatology, 2012
- Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serumExperimental Dermatology, 2011
- Increased peripheral Th17 in patients with pustulosis palmaris et plantarisArchiv für dermatologische Forschung, 2011
- Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosisBritish Journal of Dermatology, 2010
- Palmoplantar pustulosis: a clinical and immunohistological studyBritish Journal of Dermatology, 1998